Glenmark Labels As ‘Speculative’ Report Of Talks To Sell API Unit Stake

 
• By Penelope MacRae

Debt-laden Glenmark Pharmaceuticals has described as “speculative” a report that the firm is discussing with leading Indian family investment office PremjiInvest selling a minority stake in its newly hived-off API subsidiary. The company has promised to remain “proactive” in informing the Bombay Stock Exchange about corporate developments.

Cake
Glenmark Has Addressed Speculation That It Plans To Sell Off A Slice Of Its API Unit • Source: Shutterstock

More from Deals

More from Business